EDISON EQUITY RESEARCH - EKSO BIONICS
June 11 2015 - 11:37AM
InvestorsHub NewsWire
EDISON EQUITY RESEARCH: EKSO BIONICS - UNAPPRECIATED UPSIDE
POTENTIAL FROM INDUSTRIALS
The recent share price volatility is one of the risks of investing
in early stage companies like Ekso but it should not detract from
the fact that Ekso is one of the leading players in the exciting,
emerging field of assistive exoskeletons. It is the only company
that is targeting military, industrial and healthcare applications
and the third contract secured with SOCOM on the TALOS project
should illustrate the quality of its technology and engineers.
Although risk will remain, there is substantial upside potential
for those willing to ride out the volatility and hold in for the
long term.
Ekso Bionics is a pioneer in the field of human robotic
exoskeletons that augment mobility, strength and endurance. It is
development-stage company based in Richmond, California.
To view our full report, please click here
Click here to view all of Edison
Investment Research’s published reports
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2024 to May 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From May 2023 to May 2024